Diagnosis of IgG4 - related ophthalmic disease in a group of patients with various lesions of the eye and orbits


Cite item

Full Text

Abstract

Purpose of the study. To provide demographic, clinical, laboratory, ultrasound, radiological, morphological/ immunomorphological phenotype of IgG4-related ophthalmic diseases, which allowsmaking a differential diagnosis with granulomatous, autoimmune, inflammatory, endocrine and hematologic diseases affecting the eye and orbits. Materials and methods. From 2004 to 2016 108 (78.2%) of the 138 patients were diagnosed with non-tumoral lesions of eye and orbits. In 48 patients (35%) at admission and 5 patients in the follow were diagnosed IgG4-related ophthalmic disease. In the analysis of 82 (f-44, m-38) patients with IgG4-related disease, localization of lesions in orbit observed in 53 (f-36, m-17) and it was the most frequent involvement in patients with IgG4-related disease (64.5%). Only 7 patients had isolated IgG4-related ophthalmic disease, whereas 46 patients (87%) had involvement of 2-7 locations, as a manifestation of IgG4-related systemic disease.During the examination, the average age of patients with IgG4-related ophthalmic disease was 47.5 years (19-73 years). Median time to diagnosis was 52.8 months before 2004 and 36 months 2004-2016. Results. We noted the predominance of females in the ratio 2: 1 inthe group of patients with IgG4-related ophthalmic disease. Edema of the eyelids, nasal congestion (55-60%), tumor-like formations of the upper eyelids and increased lacrimation prevailed at the onset of the disease, whereas such functional impairment like limited mobility and pain in eyeballs, exophthalmos, ptosis and diplopia appeared later at 15-38% with a loss visual acuity in one case. Bilateral lesion (86%), mainly affecting the lacrimal glands (93.5%), infiltration of the extraocular muscles (83.5%) and retrobulbar tissue with a thickening of the optic nerve in one third of patients were the main localizations IgG4-related ophthalmic disease. Clinical symptoms were accompanied by the appearance of moderate inflammatory activity (38%), increased levels IgG (44%), IgG4(88%) and IgE (61%). Indicators of autoimmune disorders observed in 6-22% of patients, most often in patients with simultaneous involvement of the salivary glands. Significant lymphoplasmacytic infiltration (94%) with a ratio of plasma cells (IgG4/IgG) secreting IgG4> 40% (90%) with fibrosis formation (94%) and follicle formation (71%) with a moderate amount of eosinophils (34%) were the major morphological / immunomorphological manifestations of IgG4-related ophthalmic disease. Signs of vasculitis and obliterative phlebitis were found in a small amount of patients. Conclusion. Determination of elevated levels of IgG-4 / IgE in patients with edema, pseudotumor of the eyelid, sinusitis and increase of the palpebral lobe of the lacrimal gland suggests the presence of IgG4-related ophthalmic disease. Minimally invasive incisional biopsy of lacrimal glands and salivary glands followed by morphological / immunomorphological research is needed for the correct diagnosis. Diagnostic orbitotomy in ophthalmic hospitals in such cases is inexpedient, since it leads to the development of dry eye. Massive lymphoplasmacytic infiltration with IgG4 / IgG ratio more than 40%, advanced fibrosis in biopsiesof the orbits tissue or salivary glands when combined lesions are required for the making the diagnosis of IgG4-related ophthalmic disease.

About the authors

V I Vasilyev

V.A. Nasonova Research Institute of Rheumatology

д.м.н., проф., в.н.с. лаб. интенсивных методов терапии ревматических заболеваний ФГБНУ «НИИР им. В.А. Насоновой» Москва, Россия

T N Safonova

Research Institute of Eye Diseases

к.м.н., в.н.с. отд-ния терапевтической офтальмологии и офтальмофармакологии ФГБНУ «НИИ глазных болезней» Москва, Россия

E V Socol

V.A. Nasonova Research Institute of Rheumatology

к.м.н., м.н.с. лаб. интенсивных методов терапии ревматических заболеваний ФГБНУ «НИИР им. В.А. Насоновой» Москва, Россия

N A Probatova

N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation

проф., д.м.н., в.н.с. отдела патологической анатомии опухолей человека ФГБНУ «РОНЦ им. Н.Н. Блохина МЗ РФ» Москва, Россия

N V Kokosadze

N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation

к.м.н., с.н.с. отдела патологической анатомии опухолей человека ФГБНУ «РОНЦ им. Н.Н. Блохина МЗ РФ» Москва, Россия

A I Pavlovskaya

N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation

к.м.н., в.н.с. отдела патологической анатомии опухолей человека ФГБНУ «РОНЦ им. Н.Н. Блохина МЗ РФ» Москва, Россия

A M Kovrigina

Hematology Research Center, Ministry of Health of Russian Federation

д.б.н., зав. лаб. морфологии ФГБНУ «ГНЦ МЗ РФ» Москва, Россия

S G Radenska-Lopovok

I.M. Sechenova 1 Moscow Medical University

д.м.н., проф. кафедры патологической анатомии им. академика А.И. Струкова ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Москва, Россия

V R Gorodetsky

V.A. Nasonova Research Institute of Rheumatology

к.м.н., в.н.с. лаб интенсивных методов терапии ревматических заболеваний ФГБНУ «НИИР им. В.А. Насоновой» Москва, Россия

E B Rodionova

V.A. Nasonova Research Institute of Rheumatology

к.м.н., врач-стоматолог ФГБНУ «НИИР им. В.А.Насоновой» Москва, Россия

S G Palshina

V.A. Nasonova Research Institute of Rheumatology

к.м.н., н.с. лаб. интенсивных методов терапии ревматических заболеваний ФГБНУ «НИИР им. В.А. Насоновой» Москва, Россия

E N Aleksandrova

V.A. Nasonova Research Institute of Rheumatology

д.м.н., зав. лаб. иммунологии и молекулярной биологии ревматических заболеваний ФГБНУ «НИИР им. В.А. Насоновой» Москва, Россия

N S Shornikova

V.A. Nasonova Research Institute of Rheumatology

к.м.н., зав. 3-м ревматологическим отд-нием ФГБНУ «НИИР им. В.А. Насоновой» Москва, Россия

I V Gaiduk

A.I. Evdokimov Moscow State University of Medicine and Dentistry

к.м.н., доцент каф. хирургии полости рта ГБОУ ВПО «МГМСУ им. А.И. Евдокимова» Москва, Россия

References

  1. Gordon L.K. Orbital inflammatory disease: a diagnosis and therapeutic challenge. Eye. 2006; 20: 1196-1206. doi: 10.1038/sj.eye.6702383
  2. Jakobiec F.A, Font R.I. Orbit. In: Spencer W.H.(ed). Ophthalmic Pathology: An Atlas and Textbook, 4th ed. WB. Saunders: Philadelphia, PA, 1996: 2822-2844.
  3. Mikulicz J. Uber eine eigenartige symmetrische Erkankung der Tranen- und Mundspeicheldrusen. Beiträge zur Chirurgie: Festschrift gewidmet Theodor Billroth [German]. Stuttgart, 1892: 610-630.
  4. Gleason J.E. Idiopathic myositis involving the intraocular muscles. Ophthalmol Rec.1903; 12: 471-478.
  5. Busse O, Hochheim W. Cited by Dunnington J.H, Berke R.N. Exophthalmos due to chronic orbital myositis. Archives of ophthalmology. 1943; 30: 446-466.
  6. Симонова М.В., Васильев В.И., Корнилова Н.Н. Дифференциальная диагностика болезни Микулича и болезни Шегрена. Стоматология. 1988; 3: 71-73.
  7. Lindfield D, Attfield K, Mc Elvanney A. Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing ‘idiopathic’ from the nomenclature? Eye. 2012; 26: 623-629. doi: 10.1038/eye.2012.4
  8. Сафонова Т.Н., Васильев В.И., Лихванцева В.Г. Синдром Шегрена. Руководство для врачей. М.: Издательство Московского Университета, 2013.
  9. Morgan W.S, Castleman B.A. Clinical of “Mikulicz’s Disease: Clinicopathologic study. The American Journal of Pathology. 1953; 29: 471-503.
  10. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis. The New England Journal of Medicine. 2001; 344: 732-738. doi: 10.1056/NEJM200103083441005
  11. Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Takahashi H, Imai K. Clinical and pathological differences between Mikulicz’s desease and Sjogren’s syndrome. Rheumatology. 2005; 44: 227-234. doi: 10.1093/rheumatology/keh447
  12. Kitagawa S, Zen Y, Harada K, Sasaki M, Sato Y, Minato H, Watanabe K, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Tsuneyama K, Saito K, Haratake J, Takagawa K, Nakanuma Y. Abudant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner’s tumor). The American Journal of Surgical Pathology. 2005; 29: 783-791. doi: 10.1097/01.pas.0000164031.59940.fc
  13. Yamamoto M, Takahashi H, Naishiro Y, Isshiki H, Ohara M, Suzuki C, Yamamoto H, Kokai Y, Himi T, Imai K, Shinomura Y. Mikulicz’s disease and systemic IgG4-related plasmacytic syndrome (SIPS). Nihon Rinsho Meneki Gakkai Kaishi. 2008; 31: 1-8. doi: 10.2177/jsci.31.1
  14. Takahira M, Ozawa Y, Kawano M, Zen Y, Hamaoka S, Yamada K, Sugiyama K. Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. International Journal of Rheumatology. 2012; Article ID 635473. doi: 10.1155/2012/635473
  15. Hamed J, Tsushima K, Yasuo M, Kubo K, Yamazaki S, Kawa S, Hamano H, Yamamoto H. Inflamatory lesions of the lung, submandibular gland, bile duct and prostate in a patient with IgG4-associated multifocal systemic fibrosclerosis. Respirology. 2007; 12: 455-457. doi: 10.1111/j.1440-1843.2007.01053.x
  16. Pasquali N, Schoenfield L.S, Spalding S.J, Singh A.D. Orbital inflammation in IgG4-related sclerosing disease. Orbit. 2011; 30: 258-260. doi: 10.3109/01676830.2011.593677
  17. Седышев С.Х., Васильев В.И., Ковригина А.М., Насонов Е.Л. IgG4-связанное системное заболевание. Современный взгляд на «старые» проблемы. Научно - практическая ревматология. 2012; 5: 64-72. doi: 10.14412/1995-4484-2012-1184
  18. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern Rheumatology. 2012; 22: 1-14. doi: 10.1007/s10165-011-0508-6
  19. Stone J.H, Zen Y, Deshpande V. Ig4-Related Disease. The New England Journal of Medicine. 2012; 366: 539-551. doi: 10.1056/NEJMra1104650
  20. Masaki Y, Dong L, Rurose N, Kitagawa K, Morikawa Y, Yamamoto M, Takahashi H, Shinomura Y, Imai K, Saeki T, Azumi A, Nakada S, Sugiyama E, Matsui S, Origuchi T, Nishiyama S, Nishimori I, Nojima T, Yamada K, Kawano M, Zen Y, Kaneko M, Miyazaki K, Tsubota K, Eguchi K, Tomoda K, Sawaki T, Kawanami T, Tanaka M, Fukushima T, Sugai S, Umehara H. Proposal for a new clinical entity, IgG4-positive multi - organ lymphoproliferative syndrome: Analysis of 64 cases of IgG4-related disorders. Annals of the Rheumatic Diseases. 2009; 63: 1310-1315. doi: 10.1136/ard.2008.089169
  21. Васильев В.И., Логвиненко О.А., Седышев С.Х., Раденска-Лоповок С. Г., Родионова Е. Б., Александрова Е. Н., Пробатова Н. А., Кокосадзе Н. В., Сафонова Т. Н., Насонов Е. Л. IgG4-cвязанное заболевание. Клинические наблюдения. Научно - практическая ревматология. 2013; 5: 578-586. doi: 10.14412/1995-4484-2013-1552
  22. Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, Takata K, Morito T, Kondo E, Yoshino T. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathology International. 2008; 58: 465-470. doi: 10.1111/j.1440-1827.2008.02257.x
  23. Васильев В.И., Сокол Е.В., Седышев С.Х., Городецкий В.Р., Александрова Е.Н., Логвиненко О.А., Пальшина С.Г., Родионова Е.Б., Раденска-Лоповок С.Г., Пробатова Н.А., Кокосадзе Н.В., Павловская А.И., Ковригина А.М., Варламова Е.Ю., Сафонова Т.Н., Боровская А.Б., Гайдук И.В., Мухортова О.В., Асланиди И.П., Насонов Е.Л. Дифференциальная диагностика ревматических и онкогематологических заболеваний, поражающих полость носа и придаточных пазух носа. Терапевтический архив. 2014; 5: 62-72.
  24. Stone J.H, Khosroshahi A, Deshpande V, Chan J.K, Heathcote J.G, Aalberse R, Azumi A, Bloch D.B, Brugge W.R, Carruthers M.N, Cheuk W, Cornell L, Castillo C.F, Ferry J.A, Forcione D, Klöppel G, Hamilos D.L, Kamisawa T, Kasashima S, Kawa S, Kawano M, Masaki Y, Notohara K, Okazaki K, Ryu J.K, Saeki T, Sahani D, Sato Y, Smyrk T, Stone J.R, Takahira M, Umehara H, Webster G, Yamamoto M Yi E, Yoshino T, Zamboni G, Zen Y, Chari S. Recommendations for the Nomenclature of IgG4-Related Disease and Its Individual Organ System Manifestations. Arthritis & Rheumatology. 2012; 64: 3061-3067. doi: 10.1002/art.34593
  25. Takahashi H, Yamamoto M, Tabeya T, Suzuki C, Naishiro Y, Shinomura Y, Imai K. The immunobiology and clinical characteristics IgG4 related disease. Journal of Autoimmunity. 2012; 39: 93-96. doi: 10.1016/j.jaut.2012.01.007
  26. Mc Nab A.A, Mc Kelvie P. IgG4-Related Ophthalmic Disease. Part I: Background and Pathology. Ophthalmic Plastic and Reconstructive Surgery. 2015; 31: 83-88. doi: 10.1097/IOP.0000000000000363
  27. Mc Nab A.A, Mc Kelvie P. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects. Ophthalmic Plastic and Reconstructive Surgery. 2015; 20 (20): 1-12. doi: 10.1097/IOP.0000000000000364
  28. Goto H, Takahira M, Azumi A. Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Japanese Journal of Ophthalmology. 2015;59: 1-7. doi: 10.1007/s10384-o14-0352-2
  29. Васильев В.И., Сокол Е.В., Родионова Е.Б., Пальшина С.Г., Александрова ЕН., Раденска-Лоповок С.Г., Пробатова НА., Кокосадзе Н.В., Ковригина А.М., Сафонова Т.Н., Боровская А.Б., Гайдук И.В. Связанные с IgG-4 поражения слюнных желез. Терапевтический архив. 2015; 8: 92-102. doi: 10.1711/terarkh 201587892-102
  30. Go H, Kim J.E, Kim Y.A, Chung H.K, Khwarg S.I, Kim C.W, Jeon Y.K. Ocular adnexal IgG4-related disease: comparative analysis with mucosa - associated lymphoid tissue lymphoma and other chronic inflammatory conditions. Histopathology. 2012; 60: 296-312. doi: 10.1111/j.1365-2559.2011.04089.x
  31. Japanese study group of IgG4-related ophthalmic disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Japanese Journal of Ophthalmology. 2013; 57: 573-579. doi: 10.1007/s10384-013-0266-4
  32. Shikishima K, Kawai K, Kitahara K. Pathological evaluation of orbital tumouros in Japan: analysis of large case series and 1379 cases reported in the Japanese literature. Clinical & Experimental Ophthalmology. 2006; 34:239-244. doi: 10.1111/j.1442-9071.2006.01192.x
  33. Goto H. Review of ocular tumor. In: Goto H, editor. Practical ophthalmology. Tokyo: Bunkodo; 2008;24:2-9.
  34. Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Japanese Journal of Ophthalmology. 2005; 49: 49-55. doi: 10.1007/s10384-004-0147-y
  35. Shields J.A, Shields C.L, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part I. Ophthalmology. 2004; 111: 997-1008. doi: 10.1016/j.ophtha.2003.01.002
  36. Shinder R, Al-Zubidi N, Esmaeli B. Survey of orbital tumors at a comprehensive cancer center in the United States. Head Neck. 2011; 33: 610-614. doi: 10.1002/hed.21498
  37. Uchida K, Masamune A, Shimosegawa T, Okazaki K. Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. International Journal of Rheumatology. 2012; 2012: 358371. doi: 10.1155/2012/358371
  38. Kanno A, Nishimori I, Masamune A, Kikuta K, Hirota M, Kuriyama S, Tsuji I, Shimosegawa T. Research Committee on Intractable Diseases of Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas. 2012; 41: 835-839. doi: 10.1097/MPA. 0b013e3182480c99
  39. Sogabe Y, Ohshima K, Azumi A, Takahira M, Kase S, Tsuji H, Yoshikawa H, Nakamura T. Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefe's Archive for Clinical and Experimental Ophthalmology. 2014; 252:531-538. doi: 10.1007/s00417-013-2548-4
  40. Wallace Z.S, Deshpande V, Stone J.H. Ophthalmic manifestations of IgG4-related disease: Single - center experience and literature review. Seminars in Arthritis and Rheumatism. 2014; 43: 806-817. doi: 10.1016/j.semarthrit.2013.11.008
  41. Lindfield D, Attfield K, McElvanney A. Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing ‘idiopathic’ from the nomenclature? Eye (Lond). 2012; 26: 623-629. doi: 10.1038/eye.2012.4
  42. Mahajan V.S, Mattoo H, Deshpande V, Pillai S.S, Stone J.H. IgG4-Related Disease. Annual Review of Pathology. 2014; 9: 315-347. doi: 10.1146/annurev-pathol-012513-104708
  43. Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Reviews. Nature Reviews Rheumatology. 2014 Mar; 10(3):148-159. doi: 10.1038/nrrheum.2013.183
  44. Takahira M, Ozawa Y, Rawano M, Zen Y, Hamaoka S, Yamada K, Sugiyama K. Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. International Journal of Rheumatology. 2012; 2012: 635473. doi: 10.1155/2012/635473.
  45. Koizumi S, Kamisawa T, Kuruma S, Tabata T, Iwasaki S, Chiba K, Setoguchi K, Horiguchi S, Ozaki N. Clinical features of IgG4-related dacryoadenitis. Graefe's Archive for Clinical and Experimental Ophthalmology. 2014; 252: 491-497. doi: 10.1007/s00417-013-2541-y
  46. Wallace Z.S, Deshpande V, Mattoo H, Mahajan V.S, Kulikova M, Pillai S, Stone J.H. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis & Rheumatology. 2015; 67(9): 2466-75. doi: 10.1002/art.39205
  47. Deshpande V. The pathology of IgG4-related disease: critical issues and challenger. Seminars in Diagnostic Pathology. 2012; 29: 191-196. doi: 10.1053/j.semdp.2012.08.001
  48. Сокол Е.В., Васильев В.И., Ковригина А.М., Сафонова Т.Н., Насонов Е.Л. Связанное с IgG4 заболевание и В-клеточная клональная лимфоидная пролиферация: описание двух случаев и обзор литературы. Терапевтический архив. 2015; 87 (12): 77-84. doi: 10.17116/terarkh2015871277-84.

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies